TickerFacts.

Northwest Biotherapeutics Inc (NWBO): Free Cash Flow

Operating cash flow minus capital expenditures for the same annual period and currency, computed by TickerFacts from the filed figures. A simple proxy, not a reported figure; a year without both inputs is left out.

-$46.27M
Year ended 2025-12-31
-$49.77M
Trailing 12 months to 2026-06-30
2010-12-31: -$6.42M2011-12-31: -$14.76M2012-12-31: -$22.79M2013-12-31: -$37.80M2019-12-31: -$32.03M2024-12-31: -$58.03M2025-12-31: -$46.27M-$46.27M
2010-12-31 Free Cash Flow (USD) 2025-12-31
Period endedFree Cash FlowChange YoYSource filing
2025-12-31-$46.27Mn/m2026-04-15, From 2025-01-01
2024-12-31-$58.03Mn/a2026-04-15, From 2024-01-01
No annual figure between 2019-12-31 and 2024-12-31.
2019-12-31-$32.03Mn/a2022-03-01, From 2019-01-01
No annual figure between 2013-12-31 and 2019-12-31.
2013-12-31-$37.80Mn/m2016-03-16, From 2013-01-01
2012-12-31-$22.79Mn/m2014-04-01, From 2012-01-01
2011-12-31-$14.76Mn/m2013-04-08, From 2011-01-01
2010-12-31-$6.42Mn/a2012-04-13, From 2010-01-01

Free Cash Flow at similar companies

Companies with the same SEC industry code (Pharmaceutical Preparations), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedFree Cash FlowChange YoY
Northwest Biotherapeutics Inc (NWBO)2025-12-31-$46.27Mn/m
Cannapharmarx, Inc. (CPMD)2025-12-31-$794.6Kn/m
NRX Pharmaceuticals, Inc. (NRXP)2024-12-31-$10.64Mn/m
IGC Pharma, Inc. (IGC)2025-03-31-$4.91Mn/m
Longeveron Inc. (LGVN)2025-12-31-$18.89Mn/m
Rani Therapeutics Holdings, Inc. (RANI)2025-12-31-$18.80Mn/m
China SXT Pharmaceuticals, Inc. (SXTC)2025-03-31-$2.35Mn/m
Bespoke Extracts, Inc. (BSPK)2024-12-31-$889.8Kn/a
Dare Bioscience, Inc. (DARE)2025-12-31-$10.29Mn/m

Compare NWBO, CPMD, NRXP, IGC side by side · Screen every company in Pharmaceutical Preparations ↗